LEXISNEXIS LIFE SCIENCES SOLUTIONS
Understanding UDI Series
Gain answers to your questions about Unique Device Identification (UDI). Book time with a UDI expert for in-depth Q&A plus access to a library of tutorials and reference materials
Swissdamed managed by Swissmedic
Switzerland has established its own medical device database, Swissdamed, managed by Swissmedic, to support national regulatory oversight following its transition away from direct participation in EU systems. Swissdamed is being implemented in phases, with mandatory use of the Product Module beginning July 1, 2026. This milestone will require manufacturers placing devices on the Swiss market to submit and maintain product data directly within the Swiss system, creating additional regulatory obligations for companies operating across Europe.
LexisNexis Life Sciences simplifies that complexity. We support manufacturers across the entire product lifecycle — from initial market entry and UDI data preparation to ongoing updates, change management, and post-market compliance. Our global regulatory expertise and technology-driven solutions help ensure your device data stays accurate, synchronized, and inspection-ready, so you can focus on innovation while we help safeguard compliance.
Timeline
Related Resources
Understanding UDI
Unique Device Identification (UDI) requirements vary by country and regulatory authority. Select a health authority below to access jurisdiction-specific guidance and resources.
Need Guidance on UDI Compliance?
Understanding UDI obligations across global health authorities can be complex. Whether you are preparing for initial submission, managing product data updates, or aligning compliance across multiple markets, our regulatory experts provide practical guidance tailored to your organization’s needs.






